BBLGW

Bone Biologics Corp Warrants (BBLGW)

About Bone Biologics Corp Warrants (BBLGW)

Bone Biologics Corp. operates as a medical device company. engages in the research and development of bone regeneration in spinal fusion. Its product is Nell-1, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. Its platform technology has application in delivering improved outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. The company was founded by Eric Kang Ting, Chia Soo and Benjamin Wu in 2004 and is headquartered in Burlington, MA.

Details

Daily high
$60.50
Daily low
$60.50
Price at open
$60.50
52 Week High
$70.44
52 Week Low
$0.70
Market cap
--
Dividend yield
0.00%
Volume
1
Avg. volume
0
P/E ratio
--

Bone Biologics Corp Warrants News

Details

Daily high
$60.50
Daily low
$60.50
Price at open
$60.50
52 Week High
$70.44
52 Week Low
$0.70
Market cap
--
Dividend yield
0.00%
Volume
1
Avg. volume
0
P/E ratio
--